The largest database of trusted experimental protocols

81 protocols using cefotaxime

1

Antimicrobial Susceptibility of CTX-M Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility of blaCTX-M harbouring parent strains as well as transformants were determined by Kirby Bauer disc diffusion method and results were interpreted as per CLSI guidelines [17 ]. Following antibiotics were tested: cefotaxime (30μg), cefoxitin (30μg), ceftazidime (30μg), amikacin (30μg), gentamicin (10μg), kanamicin (30μg), ciprofloxacin (5μg), trimithoprim/sulphamethoxazole (1.25/23.75μg), imipenem (10μg), ertapenem (10μg), tigecycline (15μg) and polymyxin B (300 units) (Hi-Media, Mumbai). MIC was also determined for donor strain and transformants against cefotaxime, ceftazidime and ceftriaxone (Hi-Media, Mumbai, India) by agar dilution method.
+ Open protocol
+ Expand
2

Agrobacterium-Mediated Transformation of Sesame

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transformation in sesame explants were carried using transformed Agrobacterium tumefaciens single colony having the desired gene combination in the binary pBI121 vector. The antibiotics used in selection were kanamycin and rifampicin and the growth conditions was 200 rpm at 28 °C for 12 h. A.tumefaciens liquid culture was centrifuged at 4000× g for 10 min to pellet the cells. The cells were suspended in 50 ml of liquid MS medium and 20 µl of 20 μM acetosyringone (Murashige and Skoog 1962). The de-embryonated cotyledons were incubated in the liquid agrobacterium for 15 min and dried on sterile filter paper. Infected explants were then incubated in dark for 3 days on co-cultivation medium (pre regeneration medium + 20 μM acetosyringone). Following co-cultivation, explants were washed two times with sterile water supplemented with 500 mg/l cefotaxime (Himedia, India) and placed in pre culture media containing cefotaxime (500 mg/l) and 50 mg/l kanamycin. Explants were sub cultured with two week intervals and transferred to shoot elongation medium containing MS basal medium with 0.3 mg/l GA3.
+ Open protocol
+ Expand
3

Isolation and Identification of Antibiotic-Resistant Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pre-enriched samples were streaked onto MacConkey agar (Sigma-Aldrich) supplemented with cefotaxime and ceftazidime (HiMedia, India) at the concentration of 2 μg/mL each and incubated at 37°C for 18-24 h. One colony from each type was picked from primary growth and subcultured on the MacConkey agar plate supplemented with both cefotaxime and ceftazidime at the final concentration of 1 μg/mL. Purified isolates were identified using the procedures described by Cowan and Steel [26 ]. Biochemically confirmed isolates were stored in trypticase soy broth (TSB; Sigma-Aldrich) containing 30% glycerol at −80°C.
+ Open protocol
+ Expand
4

Antimicrobial Susceptibility Testing of Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
For initial screening, antimicrobial susceptibility testing was performed with 16 antimicrobial agents (HiMedia Laboratories Mumbai, India) namely; norfloxacin (10 μg), cefotaxime (30 μg), imipenem (10 μg), meropenem (10 μg), ceftazidime (30 μg), aztreonam (30 μg), nalidixic acid (30 μg), amoxicillin (20/10 μg), gentamicin (10 μg), ciprofloxacin (5 μg), ampicillin (10 μg), amikacin (30 μg), polymixin B (300 units/disc), cefotaxime + clavulanic acid (30/10 μg), ceftriaxone (30 μg) and Piperacillin+tazobactam (100/10 μg) on Mueller-Hinton agar plates by the Kirby Bauer disc diffusion method as per CLSI guidelines (CLSI, 2012 ) and later minimum inhibitory concentration (MIC) by E-strips (HiMedia Laboratories Mumbai, India) was performed for confirmation. Multidrug resistant (MDR) isolates show resistance to ≥3 antibiotic classes (Magiorakos et al., 2012 (link)). Escherichia coli (ATCC) strain 25922 was included as a quality control.
+ Open protocol
+ Expand
5

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility testing was done by Kirby–Bauer disc diffusion method for different classes of antibiotics such as cefotaxime (30 μg), ceftazidime (30 μg), cefoxitin (30 μg), amikacin (30 μg), and ciprofloxacin (5 μg), piperacillin/tazobactam (100 μg/10 μg), and imipenem (10 μg) (Himedia laboratories, Mumbai, Maharashtra, India) as per Clinical and Laboratory Standard Institute guidelines.[11 ] ATCC Escherichia coli 25,922 was used as control strain.
The clinical history was sought for all the K1 and K2 serotypes from the medical records.
+ Open protocol
+ Expand
6

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility testing was performed by modified Kirby Bauer's disc diffusion method on Mueller Hinton Agar medium according to the Clinical Laboratory Standard Institute guidelines (CLSI, 2013) . The antibiotics used were ciprofloxacin ((5 µg), cotrimoxazole (25 µg), cefotaxime (30 µg), ceftriaxone (30 µg), cefixime (10 µg), amikacin (30 µg), gentamycin (10 µg), ceftazidime (30 µg), cefoperazone/sulbactum (75/10 µg), meropenem (10 µg), piperacillin/tazobactam (100/10 µg), chloramphenicol (30 µg) (HiMedia, India). Suspension of bacteria maintained to 0.5 McFarland standards was inoculated on Mueller Hinton Agar (HiMedia, India) plates using sterile swabs, and then antibiotic discs were placed on it. The plates were incubated at 37 °C for 24 hours. The diameter of the zone of inhibition was measured and compared with standard strain. The results were interpreted as sensitive, intermediate, resistant according to CLSI (2013) guidelines. Pseudomonas (ATCC 27853) was used as standard control strains.
+ Open protocol
+ Expand
7

Antimicrobial Susceptibility Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amikacin (AMK; 30 μg/disk), ampicillin/sulbactam (SAM, 10/10 µg/disc), cefixime (CFM; 5 µg/disc), cefotaxime (CTX; 30 µg/disc), ceftazidime (CAZ; 30 µg/disc), ceftriaxone (CRO; 30 µg/disc), ciprofloxacin (CIP, 5 µg/disc), gentamicin (GEN, 10 µg/disc), imipenem (IPM, 10 µg/disc), meropenem (MEM; 10 µg/disc), nitrofurantoin (NIT; 300 µg/disc), sulbactam (SUL; 10 µg/disc), trimethoprim/sulfamethoxazole (SXT; 25 µg/ disc) (HiMedia Laboratories, Mumbai,. India), imipenem and sulbactam powder (Sigma-Aldrich Co. St. Louis, MO, USA). The antifungal powders were dissolved in dimethyl sulfoxide (DMSO) and stock solutions diluted based on Clinical and Laboratory Standard Institute (CLSI) guidelines (CLSI M07-A10).
+ Open protocol
+ Expand
8

Antibiotic Susceptibility of Gram-Negative Bacteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
The susceptibilities of Gram-negative bacteria (GNB) to the antimicrobial agents ampicillin (10 µg) amoxicillin/clavulanate (30 µg), cefuroxime (30 µg), cefotaxime (30 µg), chloramphenicol (30 µg), cotrimoxazole (25 µg), gentamicin (10 µg), amikacin (30 µg), ciprofloxacin (5 µg), tetracycline (30 µg) and levofloxacin (5 µg) (HiMedia Laboratories, India) were determined with Kirby-Bauer disc diffusion method in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines [16 ]. Erythromycin (30 µg), oxacillin (30 µg), and vancomycin (30 µg) were included for Gram positive bacteria (GPB). The reference strain E. coli ATCC 25922 and Staphylococcus aureus ATCC 10221 were included as quality controls in the susceptibility assays. Relative to the panel of antibiotics tested for each isolate, and according to the international standard definitions for acquired resistance, multidrug resistant (MDR) phenotype was defined as in vitro non-susceptibility to ≥1 agent in ≥3 antimicrobial categories [17 (link)]: penicillins, cephalosporins, beta-lactamase inhibitor combinations, fluoroquinolones, aminoglycosides, chloramphenicol, folate pathway inhibitors, tetracyclines, macrolides and glycopeptides.
+ Open protocol
+ Expand
9

Antibiotic Susceptibility Testing for Klebsiella

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibacterial susceptibility testing was performed using the disk diffusion method according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) documents (13 ). The antibiotics used comprised of piperacillin (100 μg), ceftazidime (30 μg), cefotaxime (30 μg), cefazoline (30 μg), tetracycline (30 μg), kanamycin (30 μg), Imipenem (10 μg), and Meropenem (10 μg) (Himedia, Mombay, India). Minimum inhibitory concentration (MIC) for Imipenem was determined by E-test method (AB Biodisk, Solna, Sweden) for all K. pneumoniae isolates according to CLSI guideline (14 (link)).
+ Open protocol
+ Expand
10

Antibiotic Susceptibility of E. marmotae

Check if the same lab product or an alternative is used in the 5 most similar protocols
The susceptibility of E. marmotae M-12 to antibiotics was determined by the standard disc-diffusion method. Testing was performed following EUCAST 2022 guidance on the Mueller–Hinton agar (Himedia). The following discs with antibiotics were used (20 antibiotics in total): amoxicillin-clavulanic acid (20–10 µg), gentamicin (10 µg), trimetoprim-sulfametoxazol (1.25–23.75 µg) (NICF, Russia); aztreonam (30 µg), piperacillin (30 µg), piperacillin-tazobactam (100–10 µg), amikacin (30 µg), tobramycin (10 µg), ticarcillin-clavulanic acid (75–10 µg), ticarcillin (75 µg) (Bioanalyse, Turkey); ampicillin (10 µg), meropenem (10 µg), imipenem (10 µg), cefotaxime (5 µg), cefepime (30 µg), ceftazidime (10 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), chloramphenicol (30 µg), trimethoprim (5 µg) (HiMedia, India).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!